November 2023 - PharmaTimes

Published on 19 October 2023

Description:

Once again PharmaTimes brings you the complete vista, the total panorama of the healthcare and pharmaceutical metropoli (new word siren!). We begin at the beginning – and that beginning is the future – and that future is now. With that considered we look at how doctors are high-fiving AI, how data is transforming treatments and how digital is igniting clinical trials. We've also got captivating and compelling content on why vaccines are evolving, the challenges of treating rare disease and the nuances of taking a Nordic approach. Changing the narrative of epilepsy and taking a different perspective on dementia completes a formidable line up.

Categories:

PharmaTimes

27 articles from this collection:

Cover

2 - Pharma Role

3 - From the editor

This month PharmaTimes presents Alantra’s annual ranking of the fastest growing pharma companies in the UK, and again there is much cause for celebration.

4-5 - Contents

6 - NEWS: Treatments

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has launched a public consultation on the potential reclassification of two progestogen-only, oral contraceptive pills containing desogestrel: Lovima 75mcg and Hana 75mcg film-coated tablets.

7 - NEWS: Collaboration

8 - NEWS: Research

9 - NEWS: Conditions

10-11 - COVER STORY: Dr Know

12 - Pharmafile

13 - TL Alexion Pharmaceuticals: Collaborating for change

14-15 - BUSINESS INSIGHT: Vaccine visionaries

16-17 - NHS - Primary goals

18 - International Clinical Trials

19 - FUTURE PROOFING: Accelerating the Pace of Antimicrobial Innovation

20-21 - TECHNOLOGY - Time after time

22-23 - DIVERSITY - Old moves

24-25 - HEALTH SERVICES: Turning point

26-28 - DATA: Flagged up

29 - TL FABRX: Another dimension

30-31 - CONDITIONS - Rare chance

32-33 - DIVERSITY: Dynamics of difference

34-35 - CONDITIONS - Current affairs

36-37 - Your moves

38 - AI: Digital – Open relationship

39 - IPT Online

40 - PharmaRole

PharmaTimes

PharmaTimes is the UK’s leading pharmaceutical magazine, tracking the trends and issues that affect the industry here in the UK, in Europe and across the world. We deliver independent, authoritative and trustworthy content through impartial, balanced and informed opinion and analysis.

PharmaTimes print and digital magazine has a distributed circulation of 19,000, reaching right across the industry into every company and every function, bridging the gap between Pharma and the NHS.

editorial@pharmatimes.com

https://pharmatimes.com/